FOXO3 and inflammatory bowel disease: Although it is not clear if and how the ileal phenotype affects the potential relationship between IBD disease burden and the FOXO3 mutation, the refractory nature of ileal CD58 as manifested across multiple clinical trials and additional meta-analysis59 60 suggests that novel targets are indeed required.